Meeting
2015 ASCO Annual Meeting
Discovery of new potentially actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing.
Authors
Mariacristina Di Marco
“L & A Seràgnoli” Department of Hematology and Oncological Sciences, University of Bologna, Bologna, Italy
Mariacristina Di Marco , Sandra Durante , Silvia Vecchiarelli , Elisa Grassi , Andrea Palloni , Valentina Indio , Annalisa Astolfi , Riccardo Panzacchi , Donatella Santini , Riccardo Casadei , Claudio Ricci , Giovanni Taffurelli , Giorgio Ercolani , Nico Pagano , Lucia Calculli , Carla Serra , Francesco Minni , Antonio Daniele Pinna , Maria A. Pantaleo , Guido Biasco
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer
Citation
J Clin Oncol 33, 2015 (suppl; abstr 4127)
DOI
10.1200/jco.2015.33.15_suppl.4127
Abstract #
4127
Poster Bd #
239
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Molecular characterization of long-term and short-term survivors of advanced pancreatic ductal adenocarcinoma.
First Author: Jesús Fuentes Antrás
Poster
2022 ASCO Annual Meeting
Evaluation of stage IV pancreatic adenocarcinomas based on mutational profiling of tumors.
First Author: Katherine E Poruk
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Clinical and molecular presentation of KRAS G12D-mutated pancreatic ductal adenocarcinoma in real-world settings.
First Author: Emma G. Sturgill